StrainFacts accurately quantifies both endogenous and live biotherapeutic product strain abundances in simulated and clinical vaginal microbiota samples
Preprint
Abstract
Live biotherapeutic products (LBPs) deliver microbial strains to modulate the host microbiota in order to promote health or treat and prevent disease. Since endogenous strains are already present, accurately evaluating LBP efficacy and mechanism of action requires distinguishing administered from endogenous strains. Although computational tools exist for inferring strains from short-read metagenomic data, few have been rigorously tested in the context of LBP treatment. Here, we assess the ability of StrainFacts, a computational tool for inferring strains from short-read metagenomic data, to estimate strain abundances and genotypes of endogenous and administered strains. We performed a simulation study of a single-strain LBP trial, modeling serial samples across a range of administered strain abundance, co-occurring endogenous strains, and sequencing depths. We found that StrainFacts accurately estimated both LBP and endogenous strain abundances and genotypes within simulated samples. We further validated methods using human vaginal microbiota samples spiked with CTV-05, the Lactobacillus crispatus strain contained in the LBP LACTIN-V, which has been shown to reduce recurrent bacterial vaginosis. Our findings demonstrate that StrainFacts can robustly assess LBP and endogenous strain colonization, abundance, and dynamics in simulated and experimental microbiota samples, supporting its utility as an analysis tool for vaginal LBP therapeutic trial data.Keywords
This publication has 19 references indexed in Scilit:
- Vaginal Lactobacillus fatty acid response mechanisms reveal a metabolite-targeted strategy for bacterial vaginosis treatmentCell, 2024
- P658 Safety and efficacy of MH002, an optimized live biotherapeutic product, for the treatment of mild to moderate ulcerative colitis: a first-in-disease, double-blind, randomized clinical trialJournal of Crohn's and Colitis, 2024
- Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulationNature Microbiology, 2022
- Fast and accurate metagenotyping of the human gut microbiome with GT-ProNature Biotechnology, 2021
- inStrain profiles population microdiversity from metagenomic data and sensitively detects shared microbial strainsNature Biotechnology, 2021
- PStrain: an iterative microbial strains profiling algorithm for shotgun metagenomic sequencing dataBioinformatics, 2020
- RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients’ Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile InfectionsClinical Infectious Diseases, 2020
- Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial VaginosisNew England Journal of Medicine, 2020
- Principles of microbiota engraftmentNature Reviews Microbiology, 2018
- Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota TransplantationCell Host & Microbe, 2018